{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T17:32:39Z","timestamp":1777915959758,"version":"3.51.4"},"reference-count":6,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Perfusion"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Unfractionated heparin remains the mainstay of anticoagulation therapy during extracorporeal membrane oxygenation (ECMO) maintenance. However, its continued use in clinical practice exposes patients to the risk of developing heparin-induced thrombocytopenia (HIT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case Report<\/jats:title>\n                    <jats:p>A 50-year-old male was diagnosed with multiple thromboses, including an intracardiac thrombi, accompanied by HIT during ECMO after cardiogenic shock related to acute myocardial infarction. The patient was successfully treated with new oral anticoagulants (NOAC), without significant complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>HIT during ECMO resulting in multiple thromboses is rare. To our knowledge, this is the first reported case of NOAC use in this context.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Although thrombocytopenia and thrombosis can occur for various reasons during ECMO maintenance, it is important to consider HIT as a potential cause. NOACs can be considered as a therapeutic option.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/02676591241227903","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T01:31:25Z","timestamp":1705627885000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Multiple thromboses, including intracardiac thrombi, accompanied by HIT during ECMO successfully treated with NOACs: A case report"],"prefix":"10.1177","author":[{"given":"Won-Sik","family":"Yun","sequence":"first","affiliation":[{"name":"Division of Cardiology, Hospital and Jeonbuk National University Medical School, Jeonbuk National University, Jeonju, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanghyo","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Hospital and Jeonbuk National University Medical School, Jeonbuk National University, Jeonju, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7752-6017","authenticated-orcid":false,"given":"Lae-Young","family":"Jung","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Hospital and Jeonbuk National University Medical School, Jeonbuk National University, Jeonju, Korea"},{"name":"Research Institute of Clinical Medicine, Jeonbuk National University, Jeonju, Korea"},{"name":"Biomedical Research Institute, Jeonbuk National University, Jeonju, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2024,1,18]]},"reference":[{"key":"bibr1-02676591241227903","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-11-709873"},{"key":"bibr2-02676591241227903","doi-asserted-by":"publisher","DOI":"10.4070\/kcj.2012.42.9.646"},{"key":"bibr3-02676591241227903","first-page":"813","volume":"6","author":"Babuin L","year":"2010","journal-title":"Vasc Health Risk Manag"},{"key":"bibr4-02676591241227903","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14575"},{"issue":"2","key":"bibr5-02676591241227903","first-page":"3","volume":"45","author":"Momin J","year":"2020","journal-title":"US Pharm"},{"issue":"3","key":"bibr6-02676591241227903","first-page":"168","volume":"10","author":"Al-Jammali Z","year":"2020","journal-title":"J Hematol Oncol Pharm"}],"container-title":["Perfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02676591241227903","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/02676591241227903","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02676591241227903","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:34:10Z","timestamp":1777656850000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/02676591241227903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,18]]},"references-count":6,"alternative-id":["10.1177\/02676591241227903"],"URL":"https:\/\/doi.org\/10.1177\/02676591241227903","relation":{},"ISSN":["0267-6591","1477-111X"],"issn-type":[{"value":"0267-6591","type":"print"},{"value":"1477-111X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,18]]},"article-number":"02676591241227903"}}